NuVasive Inc (NUVA)

67.84
0.15 0.22
NASDAQ : Health Care
Prev Close 67.99
Open 68.94
Day Low/High 67.38 / 68.94
52 Wk Low/High 36.81 / 62.95
Volume 932.58K
Avg Volume 838.10K
Exchange NASDAQ
Shares Outstanding 50.35M
Market Cap 3.36B
EPS 1.40
P/E Ratio 84.59
Div & Yield N.A. (N.A)

Latest News

NuVasive (NUVA) Stock Tumbles on Q3 Revenue Miss, Outlook

NuVasive (NUVA) Stock Tumbles on Q3 Revenue Miss, Outlook

NuVasive (NUVA) reported light revenue for the 2016 third quarter late Tuesday.

7 Unusual-Volume Stocks That Are About to Break Out

7 Unusual-Volume Stocks That Are About to Break Out

These stocks rising on unusual volume are within range of triggering big breakout trades.

Perrenial Target and Acquirer NuVasive Names New President and COO

Perrenial Target and Acquirer NuVasive Names New President and COO

The medical device company taps Jason Hannon, an 11-year company veteran, as its new president and COO, succeeding Patrick Miles, who was appointed vice chairman.

These 4 Medical Technology Stocks Really Stand Out

These 4 Medical Technology Stocks Really Stand Out

Medical technology companies are hot, says Rich Newitter, managing director at Leerink.

4 Standout Medical Technology Stocks

4 Standout Medical Technology Stocks

Medical technology companies are hot and not even climbing price-to-earnings multiples will slow down the likes of Hologic, Zimmer Biomet, Zeltiq and NuVasive.

Looking for Healthcare Stocks? Consider These Four

Looking for Healthcare Stocks? Consider These Four

These four small-cap stocks would be a healthy addition to your portfolio, says David Swank, portfolio manager for the Hood River Small-Cap Growth Fund.

Where Will a Healthy Zimmer Biomet Turn Next for Acquisitions?

Where Will a Healthy Zimmer Biomet Turn Next for Acquisitions?

Zimmer's return to growth is fueling acquisition thoughts by analysts. There are a number of possibilities.

Zimmer Biomet and NuVasive Could be a Spine-Tingling Combination

Zimmer Biomet and NuVasive Could be a Spine-Tingling Combination

Zimmer Biomet is on track to return to growth, which could signal more mergers and acquisitions within the industry.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AWRE, CRD.B, NUVA, SIRI, SNBC, TI, TI.A, TNC Downgrades: DD, HOT, TRNS, TROW, ZIXI Initiations: TRU, XTLY, YECO Read on to get TheStreet Quant Ratings' detailed report:

New Lifetime High Reached By NuVasive (NUVA)

New Lifetime High Reached By NuVasive (NUVA)

Trade-Ideas LLC identified NuVasive (NUVA) as a new lifetime high candidate

Analysts' Actions -- Darden, MetLife, Pandora, Yelp and More

Analysts' Actions -- Darden, MetLife, Pandora, Yelp and More

Here are Wednesday's top research calls, including an upgrade for Pandora, and downgrades for Darden Restaurants, MetLife and Yelp.

Bottom Fishers Rise to the Occasion

This group of nibblers triggered a modest reversal leading into the Fed’s late-afternoon minutes.

4 Medical Device Makers With Healthy-Looking Charts

4 Medical Device Makers With Healthy-Looking Charts

These medical device makers could be acquisition targets (and one buyer) following Zimmer Biomet's takeout of LDR Holding. Their charts are also buys, says technical chartist Bruce Kamich.

Zimmer's LDR Deal Could Force Others to Grow a Dealmaking Spine

Zimmer's LDR Deal Could Force Others to Grow a Dealmaking Spine

The $1 billion transaction could inspire other medical device companies and private equity firms to bend over backwards for spinal device assets.

Rival Offer for LDR Is Unlikely, but Never Say Never

Rival Offer for LDR Is Unlikely, but Never Say Never

The hefty premium Zimmer Biomet is paying in the $1 billion deal for the spine company suggests the target's management followed a competitive process.

Cramer Says Buy NuVasive on Heels of Zimmer's LDR Deal

Cramer Says Buy NuVasive on Heels of Zimmer's LDR Deal

The target's shares soar on heels of latest back treatment acquisition.

Jim Cramer: Zimmer-LDR Deal Is Great

Jim Cramer: Zimmer-LDR Deal Is Great

Zimmer Biomet's move to acquire LDR Holding is a smart one and it also bodes well for another medical device company NuVasive, said TheStreet's Jim Cramer.

NuVasive (NUVA) Hits New Lifetime High

NuVasive (NUVA) Hits New Lifetime High

Trade-Ideas LLC identified NuVasive (NUVA) as a new lifetime high candidate

Where Are the Numbers Coming From?: Jim Cramer’s Best Blogs

Where Are the Numbers Coming From?: Jim Cramer’s Best Blogs

Jim Cramer talks about how the jobs numbers baffle him and says not to give up on this market.

Jim Cramer's Top Takeaways: Ross Stores, TJX, Tesla, NXP Semiconductor, NuVasive

Jim Cramer's Top Takeaways: Ross Stores, TJX, Tesla, NXP Semiconductor, NuVasive

Cramer gives the edge to TJX over Ross Stores and is a fan of NuVasive.

Jim Cramer's 'Mad Money' Recap: Here's Why It's Time to Start Buying Stocks

Jim Cramer's 'Mad Money' Recap: Here's Why It's Time to Start Buying Stocks

When investors get complacent, they miss out on great opportunities to buy, Cramer says.

NuVasive (NUVA) Stock Upgraded at Barclays

NuVasive (NUVA) Stock Upgraded at Barclays

NuVasive (NUVA) stock was raised to 'equal weight' from 'overweight' at Barclays.

Analysts' Actions -- Deckers, Palo Alto Networks, Signet Jewelers, Workday and More

Analysts' Actions -- Deckers, Palo Alto Networks, Signet Jewelers, Workday and More

Here are Friday's top research calls, including downgrades for Deckers, Palo Alto Networks, Signet Jewelers and Workday.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ARTX, BSX, CBL, ESRT, GV, KRA, LDOS, NNBR, UTX Downgrades: BEN, CHU, DSPG, DX, NUVA, PNRG, QGEN, WBC, WRE Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

Don't Miss Today's Strong And Under The Radar Stock: NuVasive (NUVA)

Don't Miss Today's Strong And Under The Radar Stock: NuVasive (NUVA)

Trade-Ideas LLC identified NuVasive (NUVA) as a strong and under the radar candidate

Short Interest In Nuvasive Increases 14%

Short Interest In Nuvasive Increases 14%

The most recent short interest data has been released by the NASDAQ for the 03/31/2016 settlement date, which shows a 391,021 share increase in total short interest for Nuvasive Inc , to 3,165,855, an increase of 14.09% since 03/15/2016. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Today's Pre-Market Mover With Heavy Volume: NuVasive (NUVA)

Today's Pre-Market Mover With Heavy Volume: NuVasive (NUVA)

Trade-Ideas LLC identified NuVasive (NUVA) as a pre-market mover with heavy volume candidate

NuVasive (NUVA) Showing Signs Of A Dead Cat Bounce Today

NuVasive (NUVA) Showing Signs Of A Dead Cat Bounce Today

Trade-Ideas LLC identified NuVasive (NUVA) as a "dead cat bounce" (down big yesterday but up big today) candidate